The Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements entered into by the worlds leading biopharma companies.

The Hematology Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the hematology partnering deals and agreements entered into by the worlds leading healthcare companies.

The Trends in Therapeutic Partnering report provides the most comprehensive and in-depth insight into the 35 most popular therapeutic targets for partnering in the period 2009 to mid 2014.

The Molecular Diagnostics Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter molecular diagnostics partnering deals.

The Diagnostic Imaging Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the diagnostic imaging partnering agreements entered into by the worlds leading healthcare companies.

The Antibiotics Partnering Agreements report provides an understanding and access to the antibiotics partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in antibiotics partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Antibiotics partnering contract documents Top antibiotics deals by value   The Antibiotics Partnering Terms and more »

The Orphan Diseases Partnering Terms and Agreements report provides an understanding and access to the orphan diseases partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in orphan diseases partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Orphan diseases partnering contract documents Top orphan diseases deals more »

The Gene Therapy Partnering Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies.

The Infectious Vaccines Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter infectious vaccines partnering deals.

The Cancer Diagnostics Partnering Agreements report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in cancer diagnostics partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer diagnostics partnering contract documents Top cancer diagnostics deals by value   The more »

The article here analyses the recent manufacturing and supply partnering trends in the pharma industry. A supply or manufacturing agreement is normally between a product manufacturer and product owner in which an owner outsources the manufacture and supply of its product(s) to the service company in a defined territory.

Supply is the provision of goods for use or sale in response to a request or demand for the goods

Grifols is a Spanish global pharmaceutical company specialising in the supply of blood plasma products.

Manufacturing and supply agreements have long been present in the pharmaceutical industry, as companies have sought external expertise for manufacturing and supply of finished product.

By Patricia Van Arnum. John Kelly, Vice President of strategy and transitioning sites for Pfizer Global Supply, discusses the company’s manufacturing and supply strategy and network. 

US Department of Health and Human Services (HHS) has awarded a contract to SIGA Technologies for 1.7 million courses of smallpox antivirals to combat bio-warfare pathogens.

M&A hunt: Speaking at the Leerink Swann Global Healthcare Conference last week, James Foster, chief executive officer of Charles River Laboratories, indicated the company was actively looking for merger and acquisition targets in 2015.

M&A news: The Canadian pharma company Valeant Pharmaceuticals is rumoured to be raising money to make a bid for specialty drugmaker Salix Pharmaceuticals, according to Bloomberg, which cites people familiar with the matter.

This month we provide you with an overview of deal analysis in the life science sectors, covering partnering, M&A and financing in October 2014.

Pharmacyclics, listed as a new big biotech entrant in 2014, works to improve the lives of cancer affected patients by entering into strategic partnering deals to support its product pipeline.

HTG Molecular Diagnostics and OvaGene Oncology have entered a manufacturing supply agreement where OvaGene will design and develop their proprietary gene expression assays on HTG’s fully automated, extraction-free Edge Platform.

Varian Medical Systems signed a biotech deal for 3 year supply agreement. 

Arena and Eisai have entered into a marketing and supply agreement for  $1.796 billion, if all option are exercised. 

RaySearch Laboratories has entered biotech deals for its RayStation treatment planning system with Provision Center for Proton Therapy.

Myriad Genetics has entered into expanded, non-exclusive global pharma deals with AstraZeneca to provide companion diagnostics for the olaparib Phase 3 clinical development program.

Abcam pharma deals with Pfizer, a big company, entering into a supply and licensing agreement for biological compounds.

AstraZeneca enters big pharma deals with Par Pharmaceutical Companies for an exclusive U.S. supply and distribution agreement in which Par will distribute the authorized generic version of AstraZeneca’s Atacand.

Mylan, a top big pharma announced that its India-based subsidiary Mylan Laboratories Limited has been selected as a leading supplier of antiretroviral drugs to India’s National AIDS Control Organization .

AmerisourceBergen Corporation has signed a three year pharma deals agreement to supply approximately $18.5 billion in pharmaceuticals to Express Scripts on an annual basis.

Following a pharma partners agreement, Catalent has commenced supply to big pharma, Otsuka Pharmaceutical of Abilify OD Tablets which utilize Catalent’s Zydis fast dissolve drug delivery technology.